Partner Content Partner Content Inhale, Exhale: Living with Severe Asthma and Severe Eosinop... Findings from patient research about severe asthma
Views & Analysis Patient research is critical to brand success, particularly ... We see it time and time again in the treatment of cancer – pharma companies focusing all their effort on oncologists.
Views & Analysis Survey: pharma not helping online health info seekers Exclusive research with people seeking health information online in the US, UK and Canada.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
